Coherus BioSciences
CHRS
#10124
Rank
NZ$0.11 B
Marketcap
NZ$0.75
Share price
-14.34%
Change (1 day)
-65.08%
Change (1 year)

Earnings for Coherus BioSciences (CHRS)

Earnings in 2026 (TTM): -NZ$0.27 Billion

According to Coherus BioSciences 's latest financial reports the company's current earnings are NZ$50.93 Million. In 2025 the company made an earning of -NZ$0.32 Billion, an increase over its 2024 earnings that were of -NZ$0.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Coherus BioSciences from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.27 Billion-16.76%
2025 -NZ$0.32 Billion-15.4%
2024 -NZ$0.38 Billion4.1%
2023 -NZ$0.37 Billion-23.74%
2022 -NZ$0.48 Billion-1.84%
2021 -NZ$0.49 Billion-268.38%
2020 NZ$0.28 B42.13%
2019 NZ$0.20 B-155.26%
2018 -NZ$0.37 Billion-12.68%
2017 -NZ$0.42 Billion90.92%
2016 -NZ$0.22 Billion-46.49%
2015 -NZ$0.41 Billion168.87%
2014 -NZ$0.16 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$20.12 B-7,368.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$55.87 M-120.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-NZ$0.5 Billion 78.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-NZ$1.15 Billion 312.28%๐Ÿ‡บ๐Ÿ‡ธ USA